Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Health
Results: 1201-1212 of 7444
Angelalign Technology Announces First-Half 2025 Results While Increasing Investments in Legal, Supply Chain and Data Security
Over 2,000 Successful Surgeries for Drug-Resistant Epilepsy
LivaNova to Host Investor Day on November 12, 2025
PCM Trials, EmVenio Research, and Clinical Trial Service Rebrand as EmVenio Clinical Research
Peijia Medical Announces 2025 Interim Results
Alkermes to Present Detailed Positive Results From Vibrance-1 Phase 2 Study Evaluating Alixorexton in Patients With Narcolepsy Type 1 at World Sleep 2025
BeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 Million
Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy
Leqembi® (lecanemab) launched in the EU today
SBC Medical Appoints Dr. Ewen Chee as Lead Doctor for Asia Strategy to Accelerate Global Expansion
Antengene Announces 2025 Interim Results with Encouraging Clinical Data and Progress in TCE Platform
Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts
Prev
Page
1
2
…
100
101
102
…
620
621
Next
Page
